Medifast
MED
246 hedge funds and large institutions have $1.52B invested in Medifast in 2019 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 98 increasing their positions, 68 reducing their positions, and 40 closing their positions.
44% more repeat investments, than reductions
Existing positions increased: 98 | Existing positions reduced: 68
41% more call options, than puts
Call options by funds: $14.9M | Put options by funds: $10.5M
8% more capital invested
Capital invested by funds: $1.41B → $1.52B (+$112M)
6.03% more ownership
Funds ownership: 94.7% → 100.73% (+6%)
5% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 40
0% less funds holding
Funds holding: 247 → 246 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCM
Hoplite Capital Management
New York
|
+$33.3M |
| 2 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$23.7M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$15M |
| 4 |
WG
Winton Group
London,
United Kingdom
|
+$12.8M |
| 5 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
+$12.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$17.7M |
| 2 |
Goldman Sachs
New York
|
-$16.1M |
| 3 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$12.8M |
| 4 |
Morgan Stanley
New York
|
-$12.2M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$8.91M |
MED Hedge Fund Activity: Q1 2019 in Review
246 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q1 2019, worth a combined $1.52B — up 7.9% from $1.41B a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new MED positions and 40 closed out — a net gain of 2 holders — while 98 added to existing stakes and 68 trimmed.
The largest buyer was Hoplite Capital Management, opening a new position worth an estimated $33.3M. The largest seller was Renaissance Technologies, cutting an estimated $17.7M.
- 246 institutional investors held Medifast (MED) as of Q1 2019, down from 247 in Q4 2018.
- Funds reported $1.52B of Medifast stock for Q1 2019, up 7.9% quarter-over-quarter.
- 42 funds opened new Medifast positions in Q1 2019 and 40 closed out, a net change of +2 holders.
- The largest Medifast buyer in Q1 2019 was Hoplite Capital Management, an estimated $33.3M added.
- The largest Medifast seller in Q1 2019 was Renaissance Technologies, an estimated $17.7M sold.
Based on aggregated 13F filings for Q1 2019.